Business Context and Reporting Period
Company: Natural Alternatives International, Inc. (NAI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2004 (Third Quarter of Fiscal Year 2004)
Business Overview: NAI operates as a private label contract manufacturer for vitamins, minerals, and nutritional supplements, serving direct sales marketing channels and retail. The company also maintains a Direct-to-Consumer (DTC) marketing program featuring branded products developed with physicians and personalities.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2004 | Nine Months Ended Mar 31, 2004 | Comparison Period (Nine Months 2003) |
|---|---|---|---|
| Net Sales | $21.3 million | $55.2 million | $39.9 million |
| Gross Profit | $5.1 million (23.8% margin) | $13.1 million (23.7% margin) | $9.5 million (23.9% margin) |
| Operating Income | $1.0 million | $2.2 million | $0.9 million |
| Net Income | $0.9 million ($0.13 diluted EPS) | $2.0 million ($0.32 diluted EPS) | $0.9 million ($0.14 diluted EPS) |
| Cash and Equivalents | $3.2 million (Balance Sheet) | Decreased $2.3 million during the nine-month period | |
| Total Debt | $3.4 million (Current + Long-term) | Increased from $3.0 million at June 30, 2003 | |
| Working Capital | $14.2 million | Increased from $12.3 million at June 30, 2003 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 55% ($7.5 million) for the quarter and 38% ($15.3 million) for the nine months compared to the prior year. This was driven primarily by a 68% increase in private label contract manufacturing sales, offset by an 8% decline in DTC sales for the quarter.
- Profitability: Net income for the nine months ended March 31, 2004, more than doubled to $2.0 million compared to $0.9 million in the prior year. This improvement was due to higher operating income, partially offset by the absence of a $225,000 one-time gain from vitamin antitrust litigation proceeds recorded in the prior year.
- Inventory Build: Inventories increased significantly from $7.8 million to $12.3 million, a $4.4 million increase, primarily to meet customer requirements and anticipated revenue growth. This buildup contributed to a negative operating cash flow of $0.96 million for the nine-month period.
- Cost Structure: Gross margins remained stable (~23.8%) despite a 1.5 percentage point increase in material costs due to inventory reserves for slow-moving raw materials and the termination of the "Jennifer O'Neill Signature Line" brand. These costs were offset by favorable sales mix shifts and fixed cost leverage on higher sales volumes.
Guidance, Outlook, and Risks
- Outlook: Management anticipates private label contract manufacturing sales growth of 4% to 6% in the fourth quarter. DTC sales are expected to decline further in the near term due to reduced media spending and the termination of underperforming brands, though investments in upgraded television programming are planned for the second quarter of fiscal 2005.
- Capital Expenditures: The company plans to invest approximately $1.0 million in the fourth quarter for manufacturing capacity and $2.2 million in tenant improvements for new facility space in Vista, California, partially funded by a landlord allowance.
- Debt Refinancing: On May 11, 2004, NAI refinanced its credit facility, increasing capacity to $12.0 million (comprising an $8.0 million line of credit and $4.0 million in term loans). This replaced the previous $6.5 million facility.
- Risks:
- Customer Concentration: Two customers accounted for 70% of net sales in the nine months ended March 31, 2004. The loss of either would have a material adverse impact.
- Supplier Concentration: Reliance on a limited number of raw material suppliers poses a risk to operations.
- Foreign Exchange: A 10% adverse change in exchange rates (Swiss Franc/Euro vs. USD) could decrease earnings by $1.1 million.
- Valuation Allowance: A full valuation allowance was recorded on deferred tax assets due to uncertainty regarding near-term taxable income, though management anticipates a reduction in the fourth quarter if operating results remain strong.
Investor Verification Checklist
- Customer Dependency: Verify the stability of contracts with the top two customers, who represent 70% of revenue.
- Inventory Realizability: Assess the adequacy of inventory reserves given the $4.4 million increase in inventory levels and the specific write-downs taken for the terminated Jennifer O'Neill brand.
- Cash Flow Sustainability: Monitor operating cash flow, which turned negative ($0.96 million) for the nine-month period due to inventory buildup, despite positive net income.
- DTC Brand Performance: Track the performance of the new "Chopra Center Essentials" line and the impact of the upcoming television program upgrades on the "Dr. Cherry" brand.
- Debt Covenants: Review the terms of the new $12.0 million credit facility, specifically the eligibility requirements for the line of credit based on receivables and inventory balances.